ARCHIVES

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

U.S., Canada To Collaborate On Indian Health Services.

May 17, 2002

ASCO Backs Sentinel Node Biopsy In Some Early Stage Breast Cancer

September 30, 2005

In Brief: AACR, ASCO to Sponsor Joint Symposium on Oncogenes; AACI Hosts Congressional Staff

February 15, 1985

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

USPSTF Recommends Hepatitis C Screening For Baby Boomers

June 26, 2013

Avastin doubles progression-free survival in metastatic disease.

May 27, 2005